These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 32026360)

  • 21. Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients.
    Shekhar S; Kumar R; Rai N; Kumar V; Singh K; Upadhyay AD; Tripathi M; Dwivedi S; Dey AB; Dey S
    PLoS One; 2016; 11(7):e0159099. PubMed ID: 27459603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoantibodies Toward the Angiotensin 2 Type 1 Receptor: A Novel Autoantibody in Alzheimer's Disease.
    Giil LM; Kristoffersen EK; Vedeler CA; Aarsland D; Nordrehaug JE; Winblad B; Cedazo-Minguez A; Lund A; Reksten TR
    J Alzheimers Dis; 2015; 47(2):523-9. PubMed ID: 26401573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
    Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A
    Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy.
    Shoji M
    Adv Exp Med Biol; 2019; 1184():393-405. PubMed ID: 32096052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of isolated tau-reactive antibodies from the IVIG product, plasma of patients with Alzheimer's disease and cognitively normal individuals.
    Krestova M; Hromadkova L; Bilkova Z; Bartos A; Ricny J
    J Neuroimmunol; 2017 Dec; 313():16-24. PubMed ID: 29153604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human platelets tau: a potential peripheral marker for Alzheimer's disease.
    Neumann K; Farías G; Slachevsky A; Perez P; Maccioni RB
    J Alzheimers Dis; 2011; 25(1):103-9. PubMed ID: 21368381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
    Chen Z; Mengel D; Keshavan A; Rissman RA; Billinton A; Perkinton M; Percival-Alwyn J; Schultz A; Properzi M; Johnson K; Selkoe DJ; Sperling RA; Patel P; Zetterberg H; Galasko D; Schott JM; Walsh DM
    Alzheimers Dement; 2019 Mar; 15(3):487-496. PubMed ID: 30419228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathological Alterations of Tau in Alzheimer's Disease and 3xTg-AD Mouse Brains.
    Li L; Jiang Y; Hu W; Tung YC; Dai C; Chu D; Gong CX; Iqbal K; Liu F
    Mol Neurobiol; 2019 Sep; 56(9):6168-6183. PubMed ID: 30734228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer's disease.
    Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Kim SE; Lee BS; Kim GJ; Yu JS; Lim K; Kang SM; Park YH; Youn YC; An SSA; Kim S
    Alzheimers Res Ther; 2017 Dec; 9(1):98. PubMed ID: 29246249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital ELISA for the quantification of attomolar concentrations of Alzheimer's disease biomarker protein Tau in biological samples.
    Pérez-Ruiz E; Decrop D; Ven K; Tripodi L; Leirs K; Rosseels J; van de Wouwer M; Geukens N; De Vos A; Vanmechelen E; Winderickx J; Lammertyn J; Spasic D
    Anal Chim Acta; 2018 Jul; 1015():74-81. PubMed ID: 29530254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Aβ but not tau is related to brain PiB retention in early Alzheimer's disease.
    Tzen KY; Yang SY; Chen TF; Cheng TW; Horng HE; Wen HP; Huang YY; Shiue CY; Chiu MJ
    ACS Chem Neurosci; 2014 Sep; 5(9):830-6. PubMed ID: 25054847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease.
    Bartos A; Fialová L; Švarcová J
    J Alzheimers Dis; 2018; 64(3):751-760. PubMed ID: 29966192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid.
    Jia L; Qiu Q; Zhang H; Chu L; Du Y; Zhang J; Zhou C; Liang F; Shi S; Wang S; Qin W; Wang Q; Li F; Wang Q; Li Y; Shen L; Wei Y; Jia J
    Alzheimers Dement; 2019 Aug; 15(8):1071-1080. PubMed ID: 31422798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two novel blood-based biomarker candidates measuring degradation of tau are associated with dementia: A prospective study.
    Neergaard JS; Dragsbæk K; Christiansen C; Karsdal MA; Brix S; Henriksen K
    PLoS One; 2018; 13(4):e0194802. PubMed ID: 29641555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
    Sun Y; Guo Y; Feng X; Jia M; Ai N; Dong Y; Zheng Y; Fu L; Yu B; Zhang H; Wu J; Yu X; Wu H; Kong W
    J Neuroinflammation; 2020 Feb; 17(1):72. PubMed ID: 32093751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW; Shen YY; Tian DY; Bu XL; Zeng F; Liu YH; Chen Y; Yao XQ; Li HY; Chen DW; Zhou FY; Yang H; Li QM; Bao WQ; Guan YH; Zhou HD; Jin RB; Wang YJ
    J Alzheimers Dis; 2019; 69(1):169-178. PubMed ID: 30958377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
    Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R
    Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer's Disease.
    Deters KD; Risacher SL; Kim S; Nho K; West JD; Blennow K; Zetterberg H; Shaw LM; Trojanowski JQ; Weiner MW; Saykin AJ;
    J Alzheimers Dis; 2017; 58(4):1245-1254. PubMed ID: 28550246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levels of islet amyloid polypeptide in cerebrospinal fluid and plasma from patients with Alzheimer's disease.
    Schultz N; Janelidze S; Byman E; Minthon L; Nägga K; Hansson O; Wennström M
    PLoS One; 2019; 14(6):e0218561. PubMed ID: 31206565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
    Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
    J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.